AVAX Technologies, Inc. (AVXT) Stock Analysis
DELISTED 2025
What happened to AVAX Technologies, Inc. (AVXT) stock?
AVAX Technologies, Inc. (AVXT) no longer trades on public markets. It was delisted in December 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- December 2025
- Last recorded price (historical):
- $0.00 (last quote on record before the December 2025 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
AVAX Technologies, Inc. (AVXT). AVAX Technologies, Inc. is a development stage biopharmaceutical company focused on autologous cell vaccine technologies for cancer treatment. Their product candidates include M-VAX, O-VAX, and LungVax, targeting melanoma, ovarian cancer, and non-small cell lung cancer, respectively.
Last analyzed: Mar 17, 2026AVAX Technologies, Inc. (AVXT) Healthcare & Pipeline Overview
AVXT OTC Market Information
AVXT trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy AVXT shares?
No. AVXT stopped trading on public markets in December 2025, so the shares are not available through a broker. Anything you see quoted for AVXT elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before AVXT stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to AVAX Technologies, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.